Phase II Study of Sunitinib Malate, an Oral Multitargeted Tyrosine Kinase Inhibitor, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
BURSTEIN, Harold J, ELIAS, Anthony D, BAUM, Charles M, MILLER, Kathy D, RUGO, Hope S, COBLEIGH, Melody A, WOLFF, Antonio C, EISENBERG, Peter D, LEHMAN, Mary, ADAMS, Bonne J, BELLO, Carlo L, DEPRIMO, Samuel E
Published in Journal of clinical oncology (10.04.2008)
Published in Journal of clinical oncology (10.04.2008)
Get full text
Journal Article
Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma
Wilkins, Justin J., Brockhaus, Brigitte, Dai, Haiqing, Vugmeyster, Yulia, White, Joleen T., Brar, Satjit, Bello, Carlo L., Neuteboom, Berend, Wade, Janet R., Girard, Pascal, Khandelwal, Akash
Published in CPT: pharmacometrics and systems pharmacology (01.06.2019)
Published in CPT: pharmacometrics and systems pharmacology (01.06.2019)
Get full text
Journal Article
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
MOTZER, Robert J, MICHAELSON, M. Dror, LI, Jim Z, BELLO, Carlo L, THEUER, Charles P, GEORGE, Daniel J, RINI, Brian I, REDMAN, Bruce G, HUDES, Gary R, WILDING, George, FIGLIN, Robert A, GINSBERG, Michelle S, KIM, Sindy T, BAUM, Charles M, DEPRIMO, Samuel E
Published in Journal of clinical oncology (01.01.2006)
Published in Journal of clinical oncology (01.01.2006)
Get full text
Journal Article
Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
Deprimo, Samuel E, Bello, Carlo L, Smeraglia, John, Baum, Charles M, Spinella, Dominic, Rini, Brian I, Michaelson, M Dror, Motzer, Robert J
Published in Journal of translational medicine (02.07.2007)
Published in Journal of translational medicine (02.07.2007)
Get full text
Journal Article
Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib
Bello, Carlo L, Mulay, Marilyn, Huang, Xin, Patyna, Shem, Dinolfo, Melissa, Levine, Steven, Van Vugt, Andrew, Toh, Melvin, Baum, Charles, Rosen, Lee
Published in Clinical cancer research (15.11.2009)
Published in Clinical cancer research (15.11.2009)
Get full text
Journal Article
Molecular Target Modulation, Imaging, and Clinical Evaluation of Gastrointestinal Stromal Tumor Patients Treated with Sunitinib Malate after Imatinib Failure
DEMETRI, George D, HEINRICH, Michael C, BELLO, Carlo L, XIN HUANG, COHEN, Darrel P, BAUM, Charles M, MAKI, Robert G, FLETCHER, Jonathan A, FLETCHER, Christopher D. M, VAN DEN ABBEELE, Annick D, CORLESS, Christopher L, ANTONESCU, Cristina R, GEORGE, Suzanne, MORGAN, Jeffrey A, MING HUI CHEN
Published in Clinical cancer research (15.09.2009)
Published in Clinical cancer research (15.09.2009)
Get full text
Journal Article
A phase I and pharmacokinetic study of sunitinib administered daily for 2 weeks, followed by a 1-week off period
Britten, Carolyn D., Kabbinavar, Fairooz, Randolph Hecht, J., Bello, Carlo L., Li, Jim, Baum, Charles, Slamon, Dennis
Published in Cancer chemotherapy and pharmacology (01.03.2008)
Published in Cancer chemotherapy and pharmacology (01.03.2008)
Get full text
Journal Article
Effect of food on the pharmacokinetics of sunitinib malate (SU11248), a multi-targeted receptor tyrosine kinase inhibitor: results from a phase I study in healthy subjects
Bello, Carlo L, Sherman, Laurie, Zhou, Jihao, Verkh, Lev, Smeraglia, John, Mount, Janessa, Klamerus, Karen J
Published in Anti-cancer drugs (01.03.2006)
Published in Anti-cancer drugs (01.03.2006)
Get more information
Journal Article
Single- and multiple-dose disposition kinetics of sunitinib malate, a multitargeted receptor tyrosine kinase inhibitor: comparative plasma kinetics in non-clinical species
Haznedar, Joshua Ö., Patyna, Shem, Bello, Carlo L., Peng, Geoffrey W., Speed, William, Yu, Xiaoming, Zhang, Qingling, Sukbuntherng, Juthamas, Sweeny, David J., Antonian, Lida, Wu, Ellen Y.
Published in Cancer chemotherapy and pharmacology (01.09.2009)
Published in Cancer chemotherapy and pharmacology (01.09.2009)
Get full text
Journal Article
Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis
Houk, Brett E, Bello, Carlo L, Poland, Bill, Rosen, Lee S, Demetri, George D, Motzer, Robert J
Published in Cancer chemotherapy and pharmacology (01.07.2010)
Published in Cancer chemotherapy and pharmacology (01.07.2010)
Get full text
Journal Article
Changing Body Weight–Based Dosing to a Flat Dose for Avelumab in Metastatic Merkel Cell and Advanced Urothelial Carcinoma
Novakovic, Ana M., Wilkins, Justin J., Dai, Haiqing, Wade, Janet R., Neuteboom, Berend, Brar, Satjit, Bello, Carlo L., Girard, Pascal, Khandelwal, Akash
Published in Clinical pharmacology and therapeutics (01.03.2020)
Published in Clinical pharmacology and therapeutics (01.03.2020)
Get full text
Journal Article
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
Demetri, George D, van Oosterom, Allan T, Garrett, Christopher R, Blackstein, Martin E, Shah, Manisha H, Verweij, Jaap, McArthur, Grant, Judson, Ian R, Heinrich, Michael C, Morgan, Jeffrey A, Desai, Jayesh, Fletcher, Christopher D, George, Suzanne, Bello, Carlo L, Huang, Xin, Baum, Charles M, Casali, Paolo G
Published in The Lancet (British edition) (14.10.2006)
Published in The Lancet (British edition) (14.10.2006)
Get full text
Journal Article
A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease
Fiedler, Walter, Serve, Hubert, Döhner, Hartmut, Schwittay, Michael, Ottmann, Oliver G., O'Farrell, Anne-Marie, Bello, Carlo L., Allred, Randy, Manning, William C., Cherrington, Julie M., Louie, Sharianne G., Hong, Weiru, Brega, Nicoletta M., Massimini, Giorgio, Scigalla, Paul, Berdel, Wolfgang E., Hossfeld, Dieter K.
Published in Blood (01.02.2005)
Published in Blood (01.02.2005)
Get full text
Journal Article
Pharmacokinetics of sunitinib malate in subjects with hepatic impairment
Bello, Carlo L., Garrett, May, Sherman, Laurie, Smeraglia, John, Ryan, Bob, Toh, Melvin
Published in Cancer chemotherapy and pharmacology (01.09.2010)
Published in Cancer chemotherapy and pharmacology (01.09.2010)
Get full text
Journal Article
Pharmacokinetics and safety of sunitinib malate in subjects with impaired renal function
Khosravan, Reza, Toh, Melvin, Garrett, May, La Fargue, Joann, Ni, Grace, Marbury, Thomas C, Swan, Suzanne K, Lunde, Norman M, Bello, Carlo L
Published in Journal of clinical pharmacology (01.04.2010)
Published in Journal of clinical pharmacology (01.04.2010)
Get more information
Journal Article
Effect of food or proton pump inhibitor treatment on the bioavailability of dacomitinib in healthy volunteers
Ruiz-Garcia, Ana, Masters, Joanna C, Mendes da Costa, Laure, LaBadie, Robert R, Liang, Yali, Ni, Grace, Ellery, Craig A, Boutros, Tanya, Goldberg, Zelanna, Bello, Carlo L
Published in Journal of clinical pharmacology (01.02.2016)
Published in Journal of clinical pharmacology (01.02.2016)
Get more information
Journal Article